Spruce Biosciences Inc (SPRB): Next-Year EPS Estimate 83.05%
As of 2026-06-04, Spruce Biosciences Inc (SPRB) has a next-year EPS growth estimate of 83.05%.
SPRB was first flagged by our screen on 2026-06-01, when analyst consensus for its next-year EPS growth was revised from 80.44% to 83.05%. Current-year growth is projected at 55.05%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 83.05%
- EPS growth this year
- 55.05%
- EPS next quarter (est)
- -$5.15
- Last price
- $53.17
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 83.05% | 55.05% | -$5.15 | $53.17 |
| 2026-06-03 | 83.05% | 55.05% | -$5.15 | $49.05 |
| 2026-06-02 | 83.05% | 55.05% | -$5.15 | $49.30 |
| 2026-06-01 | 83.05% | 55.05% | -$5.15 | $50.70 |
| 2026-05-31 | 80.44% | 50.91% | -$5.65 | $51.27 |
| 2026-05-28 | 80.44% | 50.91% | -$5.65 | $49.19 |
| 2026-05-27 | 80.44% | 50.91% | -$5.65 | $49.52 |
| 2026-05-26 | 85.22% | 48.13% | -$5.92 | $51.81 |
| 2026-05-25 | 85.22% | 48.13% | -$5.92 | $51.08 |
| 2026-05-24 | 85.22% | 48.13% | -$5.92 | $51.08 |
| 2026-05-21 | 85.22% | 48.13% | -$5.92 | $52.70 |
| 2026-05-20 | 85.22% | 48.13% | -$5.92 | $51.51 |
| 2026-05-19 | 85.22% | 48.13% | -$5.92 | $48.25 |
| 2026-05-18 | 85.22% | 48.13% | -$5.92 | $51.41 |
| 2026-05-17 | 85.22% | 48.13% | -$5.92 | $53.78 |
| 2026-05-14 | 85.22% | 48.13% | -$5.92 | $59.00 |
| 2026-05-13 | 42.69% | 35.98% | -$7.73 | $58.70 |
| 2026-05-12 | 42.69% | 35.98% | -$7.93 | $56.67 |
| 2026-05-11 | 42.69% | 35.98% | -$7.93 | $56.40 |
| 2026-05-10 | 42.69% | 35.98% | -$7.93 | $56.50 |
| 2026-05-07 | 42.69% | 35.98% | -$7.93 | $56.57 |
| 2026-05-06 | 42.69% | 35.98% | -$7.93 | $57.87 |
| 2026-05-05 | 42.69% | 35.98% | -$7.93 | $59.34 |
| 2026-05-04 | 42.69% | 35.98% | -$7.93 | $59.37 |
| 2026-05-03 | 42.69% | 35.98% | -$7.93 | $57.28 |
| 2026-04-30 | 42.69% | 35.98% | -$7.93 | $57.32 |
| 2026-04-29 | 42.69% | 35.98% | -$7.93 | $55.52 |
| 2026-04-28 | 42.69% | 35.98% | -$7.93 | $54.77 |
| 2026-04-27 | 42.69% | 35.98% | -$7.93 | $57.18 |
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Spruce Biosciences Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Spruce Biosciences Inc (SPRB) has a next-year EPS growth estimate of 83.05%, based on analyst consensus.
When was the latest EPS estimate revision for SPRB?▾
The most recent revision occurred on 2026-06-01, when analysts adjusted the next-year EPS growth estimate from 80.44% to 83.05%.
What sector and industry does Spruce Biosciences Inc belong to?▾
Spruce Biosciences Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. SPRB appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Spruce Biosciences Inc (SPRB) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports